U.S. Anesthesia Partners has urged a Texas federal court to end the Federal Trade Commission's case accusing the group of buying competing practices through a so-called rollup strategy, asserting that enforcers have no evidence of any harm to competition.
Continue Reading
Sign up for FREE to read the full article and access 129K+ alternative investment headlines.